Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Treatment of tamoxifen-resistant MCF-7 breast cancer cells with either gefitinib ('Iressa') or trastuzumab (Herceptin((R))) generates cross-resistant phenotypes [Abstract]

Hutcheson, Iain Robert, Gee, Julia Margaret Wendy, Barrow, Denise, Jones, Helen E., Wakeling, A. E. and Nicholson, Robert Ian 2004. Treatment of tamoxifen-resistant MCF-7 breast cancer cells with either gefitinib ('Iressa') or trastuzumab (Herceptin((R))) generates cross-resistant phenotypes [Abstract]. Breast Cancer Research and Treatment 88 (S1) , S145-S146. 10.1007/s10549-004-3602-z

Full text not available from this repository.
Item Type: Article
Date Type: Publication
Status: Published
Schools: Pharmacy
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RM Therapeutics. Pharmacology
Additional Information: Abstract for 27th Annual The Charles A. Coltman, Jr. San Antonio Breast Cancer Symposium
Publisher: Springer Verlag
ISSN: 0167-6806
Last Modified: 05 Aug 2018 02:13
URI: http://orca-mwe.cf.ac.uk/id/eprint/17194

Actions (repository staff only)

Edit Item Edit Item